Stock screener

FULC

SetupConviction 57LongHealthcareScan · Thu, Sep 24, 2026
Flat baseDragonfly dojibase

Fulcrum Therapeutics, Inc. (FULC) closed at $3.79 (-0.52%) on Sep 24, 2026. It is in the "Setting up" lane with a flat base pattern. Price is above its 50-day and below its 200-day moving average. RSI(14) 47, RS Rating 32, -74.0% from its 52-week high, -65.3% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

FULC$3.79-0.52%
ResistanceSupportVol 14Insider buyInsider sell
63 bars
2
Vol MA14 1.54M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Trade plan

LongReward : Risk0.94
Entry
Entry
3.86
Risk
Stop
3.74
-3.0% to stop
Reward
Target 1
3.97
+2.9% to target
Stretch
Target 2
4.08
+5.7% to T2
Risk : reward balance
Risk to stopReward to target

Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.

Fulcrum Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.fulcrumtx.com ↗
Price3.79
Change-0.52%
Gap-0.66%
Rel volume4.08×
Avg volume1.54M
Avg $ vol5.88M
SMA 203.82
SMA 503.78
SMA 2006.90
Price vs 50+0.37%
Price vs 200-45.08%
MA stackmixed
50/200 cross—
Supertrenddown · 3.98
RSI (14)47
MACD hist-0.00
MACD cross—
Stoch %K / %D39 / 47
ADX (14)6
+DI / −DI15 / 17
RSI divergence—
MACD divergence—
ATR %2.05%
ADR %1.65%
52w high14.60
52w low3.14
From 52w high-74.04%
Above 52w low+20.70%
New 52w highNo
SqueezeOn · 54d
Bollinger width3.62%
%B0.29
Donchian pos26.47%
Donchian high3.92
Donchian low3.75
AVWAP (52w high)6.25
vs AVWAP high-39.32%
AVWAP (52w low)3.57
vs AVWAP low+6.05%
OBV trendDown
Chaikin MF (20)0.08
Today vs 20d4.08×
Avg vol (14d)1.54M
Avg vol (20d)1.54M
Avg $ vol (20d)5.88M
Market cap289.17M
RS Rating32 / 99
RS 3m (vs SPY)+0.49%
RS 6m (vs SPY)-62.52%
RS line new highNo
Trend template2/8
Technical rank29.1
1 week+0.53%
1 month-1.81%
3 months+4.99%
6 months-45.70%
1 year-48.44%
YTD-65.29%
P/E-3.86
P/B0.93
P/S—
P/FCF-4.79
EPS-1.18
Div yield—
ROE-24.10%
ROA-23.11%
Debt/Eq—
Current31.35
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-669.97%
Price target3.00
Target upside-20.84%
Analyst ratingSell
Institutional108.87%
Ent. value240.7M
Revenue7.8M
Net income-26.18M
Gross profit—
Free cash flow-60.38M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out66.63M
Employees55
ListedThu, Jul 18, 2019
Free float61.44M
Float %92.2%
Short interest7.02M
Days to cover3.4d
Short volume45.1%
Squeeze score58 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.21 vs −$0.21
Last surprise0.0% beat
Setup gradeC
Conviction57 / 100
Pattern quality71%
Tech rank29.1 / 100
Group rank59 / 100
Status laneSetting up
Setup directionLong
Pattern familyBase
Resistance3.86
Support3.75
Days since event—
Candle confirmDragonfly doji

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in FULC

All disclosures →
No recent disclosed trades by Congress in FULC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in FULC · open-market 4 buys · 1 sell

InsiderSideShares
TANG KEVIN
10% owner · Common Stock · 2026-07-15
Buy107.38K
TANG KEVIN
10% owner · Common Stock · 2026-07-14
Buy53.65K
TANG KEVIN
10% owner · Common Stock · 2026-07-14
Buy75.95K
TANG KEVIN
10% owner · Common Stock · 2026-07-13
Buy12.97K
Ezekowitz Alan
Director · Common Stock · 2026-06-26
Sell18K
Lehrer-Graiwer Joshua
Director · Stock Option (right to buy) · 2026-04-23
Grant64K

SEC filings

EDGAR filings in FULC · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.